GSK plc (ADR) share price logo

GSK plc (ADR)

NASDAQ: GSK

Large Cap

$50.30

-0.60

(-1.18%)

as on

GSK plc (ADR) Stock Performance

as on August 13, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $49.87
    $50.47
    downward going graph

    0.85%

    Downside

    0.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $37.80
    $61.70
    downward going graph

    24.85%

    Downside

    22.65%

    Upside

    downward going graph

GSK plc (ADR) share price movements today

Previous Close
$50.90
Open
$50.11
Volume
3.4M
Day's Low - High
$49.87 - $50.47
52 Week Low - High
$37.80 - $61.70

GSK plc (ADR) Historical Returns

1 Month Return
-2.66 %
3 Month Return
-0.18 %
1 Year Return
+ 30.08 %
3 Year Return
+ 44.07 %
5 Year Return
-2.98 %

GSK plc (ADR) Stock Fundamentals & Key Indicators

Check GSK plc (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$104.5B

EPS (TTM)

4.7496

Dividend Yield

3.43%

Quarterly Earnings Growth YOY

-0.69%

PE Ratio (TTM)

16.72

Industry PE ratio

10.315555555555555

PEG Ratio

106.9646

EBITDA

10.8B

Revenue (TTM)

33.2B

Profit Margin

14.52%

Return On Equity TTM

33.38%

GSK plc (ADR) Stock Valuation

Track how GSK plc (ADR) P/E has moved over time to understand its valuation trends.

GSK plc (ADR) in the last 5 years

  • Overview

  • Trends

Lowest (8.72x)

September 30, 2025

Industry (10.32x)

August 13, 2026

Today (16.72x)

August 13, 2026

Highest (13.70x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 16.72x

GSK plc (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GSK plc (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
GSK plc (ADR) image
GSK plc (ADR)
BUY$104.5B-2.98%16.7214.52%3.4299999999999997%
Eli Lilly & Co. image
Eli Lilly & Co.
BUY$1.1T359.87%39.8433.53%0.54%
AstraZeneca PLC image
AstraZeneca PLC
BUY$251.1B171.46%24.1717.02%2%
ABBVIE INC. image
ABBVIE INC.
BUY$438.2B114.71%69.469.80%2.78%
Johnson & Johnson image
Johnson & Johnson
BUY$630.9B47.4%30.0221.48%2.02%
See all

Stock Returns calculator for GSK plc (ADR) Stock including INR - Dollar returns

The GSK plc (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

GSK plc (ADR) investment value today

Current value as on today

₹1,39,865

Returns

₹39,865

(+39.86%)

Returns from GSK plc (ADR) Stock

₹28,546 (+28.55%)

Dollar Impact

₹11,319 (+11.32%)

Analyst Recommendation on GSK plc (ADR) Stock

Based on 33 analysts

BUY

60.61%

Buy

30.30%

Hold

9.09%

Sell

Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for GSK plc (ADR). Average target price of $58.08

GSK plc (ADR) Share Price Target

Get share price movements and forecasts by analysts on GSK plc (ADR).

What analysts predicted

13.4%UPSIDE

Target Price

$58.08

Current Price

$50.3

Analyzed by

33 Analysts

Target

$58.08

GSK plc (ADR) target price $58.08, a slight upside of 13.4% compared to current price of $50.3. According to 33 analysts rating.

Indian Investors' Interest in GSK plc (ADR) Stock

Search interest for GSK plc (ADR) Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:19% versus previous 30 day period

GSK plc (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
9,358
10,020
10,581
10,262
9,698
7,986
8,547
8,618
7,629
8,409
Gross Profit
6,854
7,323
7,415
7,026
7,199
5,821
6,289
5,961
5,754
6,143
Operating Income
1,490
1,646
189
696
2,216
2,023
2,593
1,506
2,293
481
EBITDA
2,070
2,308
1,171
1,119
3,093
3,230
3,361
1,906
2,774
2,826
Interest Expense
166
174
156
144
162
184
167
174
167
182
Depreciation
549
639
951
412
823
1,159
738
-406
463
2,290
Income Before Tax
1,355
1,495
64
563
2,108
1,887
2,456
950
2,144
354
Income Tax Expense
274
191
-1
62
336
241
312
223
305
-199
Net Income
1,329
1,490
-76
523
2,095
1,443
2,013
636
1,737
435
Net Profit Margin
14.21%
14.88%
-0.72%
5.10%
21.61%
18.07%
23.55%
7.38%
22.77%
5.17%

GSK plc (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
34,795
40,461
39,032
44,193
32,713
32,855
35,696
38,395
39,667
32,667
Gross Profit
23,204
26,599
26,062
28,661
22,063
21,995
24,066
27,551
28,228
23,650
Operating Income
2,598
4,087
5,483
6,961
5,979
4,357
6,433
6,745
4,021
8,338
EBITDA
4,430
6,184
7,350
9,220
8,067
6,485
8,601
9,083
6,668
10,402
Interest Expense
736
734
743
912
892
784
855
775
657
687
Depreciation
-
1,922
1,856
2,334
2,351
2,524
2,298
1,527
2,551
2,314
Income Before Tax
1,939
3,525
4,800
6,221
5,170
3,599
5,628
6,064
3,477
7,401
Income Tax Expense
877
1,356
754
953
67
83
707
756
526
1,112
Net Income
1,137
2,053
4,588
6,081
7,722
5,833
18,206
6,238
3,255
5,716
Net Profit Margin
3.27%
5.08%
11.75%
13.76%
23.61%
17.76%
51.00%
16.25%
8.21%
17.50%

GSK plc (ADR) Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1,304
65
501
1,772
1,646
2,714
627
1,839
437
Operating Cash Flow
1,113
2,154
2,329
1,145
2,096
3,027
2,036
1,141
2,535
Investing Cash Flow
770
-731
-1,119
-1,144
-625
-2,150
-2,362
-1,466
-880
Financing Cash Flow
-1,584
-1,240
-842
858
-2,372
-1,706
808
272
-1,903
Change in Cash
291
149
375
848
-927
-494
97
-51
-312

GSK plc (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,169
4,046
5,268
6,388
5,096
4,921
6,125
2,951
5,590
Operating Cash Flow
6,918
8,421
8,020
8,441
7,952
7,403
7,890
6,554
7,142
Investing Cash Flow
-1,443
-1,553
-5,354
2,161
-1,777
-8,772
-2,404
-1,229
-5,722
Financing Cash Flow
-6,380
-6,389
-1,840
-10,132
-7,589
823
-6,068
-4,726
-1,593
Change in Cash
-1,005
487
744
431
-1,443
-394
-735
545
-206

Global Institutional Holdings in GSK plc (ADR)

Funds
Holdings
Bank of Montreal
0.23%
BMO Capital Markets Corp.
0.23%
Dodge & Cox
2.93%
Goldman Sachs Group Inc
0.31%
Wellington Management Company LLP
0.59%
See all

GSK plc (ADR) News & Key Events

  • img

    Today's Timeline - 28 July

    Tue, 04:03 PM

    -

    GSK's partner Hansoh Pharmaceuticals reports positive trial results for a bone cancer drug.

    Tue, 07:15 PM

    -

    GSK plans to close Stevenage site, relocating 1,000 staff to a new R&D facility in Cambridge.

    Tue, 11:00 PM

    -

    GSK reports better-than-expected Q2 results, raising savings target and reaffirming growth outlook.

Insights on GSK plc (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    GSK plc's American Depositary Shares have shown positive revenue trends over the last two quarters. Revenue increased from $7.62 billion to $8.40 billion, reflecting an average growth of 9.3% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Eli Lilly & Co. has given 84.8% return, outperforming this stock by 56.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 131.0% return, outperforming this stock by 88.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    GSK plc's American Depositary Shares have seen a significant decline in net profit over the last two quarters. The net profit decreased from $1.73 billion to $434.99 million, which represents an average decrease of 75.0% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GSK stock has moved down by -3.6%

About GSK plc (ADR)

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
OrganisationGSK plc (ADR)
Headquarters79 New Oxford Street, London, United Kingdom, WC1A 1DG
IndustryDrug Manufacturers - General
CEOMr. Luke Victor Miels
E-voting on sharesClick here to vote

Key Management of GSK plc (ADR)

Name

Title

Ms. Julie Belita Brown A.C.A.

CFO & Executive Director

Ms. Emma Natasha Walmsley

Executive Officer

Dr. Jesse L. Goodman M.D., M.P.H.

Scientific & Medical Expert

Mr. Luke Victor Miels

CEO & Director

Ms. Shobie Ramakrishnan

Chief Digital & Technology Officer

Mr. Tony Wood

Chief Scientific Officer and Head of R&D

Mr. Constantin Fest

Senior VP & Head of Investor Relations

Mr. James Ford

Senior VP and Group General Counsel of Legal & Compliance

Mr. David Simon Redfern BSc (Hons), CA

President of Corporate Development

Ms. Roanne Parry

Chief People Officer

FAQs

What is GSK plc (ADR) share price today?

GSK plc (ADR) share price today is $50.30 as on at the close of the market. GSK plc (ADR) share today touched a day high of $50.47 and a low of $49.87.

What is the 52 week high and 52 week low for GSK plc (ADR) share?

GSK plc (ADR) share touched a 52 week high of $61.70 on and a 52 week low of $37.80 on . GSK plc (ADR) stock price today i.e. is closed at $50.30,which is 18.47% down from its 52 week high and 33.07% up from its 52 week low.

What is GSK plc (ADR)'s market capitalisation today?

GSK plc (ADR) market capitalisation is $0.10T as on .

How to invest in GSK plc (ADR) Stock (GSK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GSK plc (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in GSK plc (ADR) Shares that will get you 0.0298 shares as per GSK plc (ADR) share price of $50.30 per share as on August 13, 2026 at 8:46 am IST.

What is the minimum amount required to buy GSK plc (ADR) Stock (GSK) from India?

Indian investors can start investing in GSK plc (ADR) (GSK) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in GSK plc (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on GSK plc (ADR) share’s latest price of $50.30 as on August 13, 2026 at 8:46 am IST, you will get 0.1988 shares of GSK plc (ADR). Learn more about fractional shares .

What are the returns that GSK plc (ADR) has given to Indian investors in the last 5 years?

GSK plc (ADR) stock has given -2.98% share price returns and 28.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?